Views | |
---|---|
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 42 |
April 2024 | May 2024 | June 2024 | July 2024 | August 2024 | September 2024 | October 2024 | |
---|---|---|---|---|---|---|---|
Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron | 0 | 0 | 5 | 17 | 14 | 5 | 1 |
Views | |
---|---|
2023_Kreye_etal.pdf | 8 |